Endocrinology & Diabetes CME

Credits: 0.50 CME
Penn State College of Medicine
An Update on SGLT2 Inhibition for the Prevention and Treatment of Kidney Disease in Patients With Type 2 Diabetes
John B. Buse, MD, PhD
13 June, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Diminishing the Burden of Phenylketonuria During Adulthood: New Science & Encouraging Stories Highlighting the Critical Role of Adjunctive Therapy in Alleviating Neurocognitive Symptoms and Easing Dietary Constraints
Jerry Vockley, MD, PhD
30 May, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Realizing Your Patient's Potential: Embracing the Guidelines to Appropriately Individualize Care for Patients With Type 2 Diabetes
John Anderson, MD
17 April, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease
Loren del Mar Pena, MD, PhD
8 November, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Rethinking Successful Care for Pancreatic Cancer: Therapeutic Sequencing, Innovative Strategies, and Patient Perspectives on Disease Management
Johanna Bendell, MD
5 July, 2018
Credits: 0.50 CME
Purdue University
The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Considerations
Silvio Inzucchi, MD
29 June, 2018